Trevi Therapeutics Provides Update on Haduvio's Clinical Development Program

Go back to Trevi Therapeutics Provides Update on Haduvio's Clinical Development Program
(NASDAQ: TRVI) Delayed: 14.42 --0 (-0%)
Previous Close $14.42    52 Week High $ 
Open $14.42    52 Week Low $ 
Day High $14.42    P/E N/A 
Day Low $14.42    EPS $ 
Volume 396